Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Low Risk

Score: 25/100

Failure Rate

10.0%

2 terminated/withdrawn out of 20 trials

Success Rate

88.9%

+2.4% vs industry average

Late-Stage Pipeline

55%

11 trials in Phase 3/4

Results Transparency

0%

0 of 16 completed trials have results

Key Signals

Enrollment Performance

Analytics

Phase 4
11(61.1%)
N/A
7(38.9%)
18Total
Phase 4(11)
N/A(7)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (20)

Showing 20 of 20 trials
NCT06661083Not ApplicableCompleted

The Effect of Natural Molecules on HPV Infection

Role: lead

NCT01244399Completed

Influence of "Espresso" on Adsorption of Myo-inositol

Role: lead

NCT01267604Phase 4Withdrawn

Ovarian Stimulation: Inositol and Melatonin

Role: lead

NCT01828710Not ApplicableCompleted

Myo-inositol on Human Semen Parameters

Role: lead

NCT01246310Not ApplicableTerminated

Myoinositol for the Treatment of Ovarian and Psychiatric Disorder in Polycystic Ovary Syndrome (PCOS) Patients

Role: lead

NCT02050672Not ApplicableCompleted

Effect of Myoinositol Treatment of Spermatozoa on in Vitro Fertilization Outcome

Role: lead

NCT04615767Not ApplicableCompleted

D-chiro-inositol Increases Androgens and Reduces Estrogens in Human Serum

Role: lead

NCT04645745Not ApplicableCompleted

Myo-inositol, Alpha-Lactalbumin and Folic Acid Treatment in PCOS

Role: lead

NCT02016495Phase 4Completed

Efficacy of Magnesium and Alpha Lipoic Acid Supplementation in Reducing Premature Uterine Contractions

Role: lead

NCT02014428Phase 4Completed

Oral Low-molecular Weight Hyaluronic Acid in the Treatment of Atrophic Vaginitis

Role: lead

NCT01740245Phase 4Completed

Antisepsis Regimen in the Surgical Treatment of Human Papilloma Virus Generated Cervical Lesions: Polyhexamethylene Biguanide Versus Chlorhexidine

Role: lead

NCT01571141Phase 4Completed

Polyhexamethylene Biguanide Increases the Regression Rate of Human Papillomavirus (HPV) Infection

Role: lead

NCT01560065Phase 4Completed

Effect of Treatment With Myo-inositol on Human Semen Parameters in Patients Undergoing In Vitro Fertilization Cycles

Role: lead

NCT01540747Phase 4Completed

Role of Melatonin Supplementation in Follicular Fluid of in Vitro Fertilization (IVF) Patients With Polycystic Ovarian Syndrome

Role: lead

NCT01538602Completed

Mean Platelet Volume and TXA2 Levels in Patients With Polycystic Ovary Syndrome (PCOS)

Role: lead

NCT01514942Phase 4Completed

Myo-inositol Versus D-chiro-inositol in the Treatment of Polycystic Ovary Syndrome and Insulin Resistance: Evaluation of Clinical, Metabolic, Endocrine and Ultrasound Parameters

Role: lead

NCT01511822Phase 4Completed

Clinical, Metabolic and Endocrine Effects of the Treatment With Drospirenone and Ethinyl Estradiol Alone or in Combination With Myo-inositol in Young Women With Polycystic Ovary Syndrome (PCOS) and Insulin Resistance

Role: lead

NCT01511835Phase 4Unknown

Efficacy of Myo-inositol in Preventing Gestational Diabetes in High-risk Pregnant Women

Role: lead

NCT01338844Phase 4Completed

Role of Myo-inositol and D-chiro-inositol on Oocyte Quality

Role: lead

NCT01325389Not ApplicableUnknown

Myo-inositol Plus Melatonin in Perimenopausal Women

Role: lead

All 20 trials loaded